Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Post by DavidRosenbergon Mar 17, 2023 10:21am
158 Views
Post# 35344784

FSD Pharma $HUGE 3 biotech assets and 1 alcoholism r&d

FSD Pharma $HUGE 3 biotech assets and 1 alcoholism r&d

I'm saying in general people can do 200 things right and the one time something doesn't go right , you are criticized nonstop.. 

for fsd luckily they were able to sell the cannabis facility for 16.4million dollars 

I wish they never hired raza bokhari as ceo but maybe due to all those things happen they were able to acquire lucid in this reality in this time and space 

coincidentally cannabis bubble burst 

ltime to focus on positive things with 3 biotech assets and 1 alcoholism r&d 

since they hired Kevin Harrington for his experience with Celsius holdings that company is today around 6 billion market cap $celh and Kevin was early investor and mentor to them 

not saying fsd will be like Celsius but they have capable advisor 
 


I want to see updates on the clinical trial stuff and on the alcoholism project

 

<< Previous
Bullboard Posts
Next >>